New Delhi, April 3 India is unlikely to be significantly affected by US President Donald Trump's announcement of 100 per cent tariffs on certain patented drugs, as the country primarily exports low-cost generic medicines to America, think tank GTRI said on Friday.Trump signed an executive...
drug exports
drug imports
drugindustry
export trade
generic medicines
gtri
india
international trade
pharmaceutical industry
pharmaceuticals
section 232
trade agreements
trade tariffs
united states
us trade policy